Table 1.
Reference | Age at diagnosis, sex | Symptoms in childhood | K+ (mEq/l) | Bicarbonate (mEq/l) |
Growth | Other metabolic abnormalities | Genetic sequencing |
---|---|---|---|---|---|---|---|
Li et al. [23] | 32 years, female | Polyhydramnios, polyuria, polydipsia | 2.4–4.0 | 27.5–31.4 | Normal | Nephrocalcinosis, hypercalciuria; high urine chloride, hyperparathyroidism, hyperreninemia |
Compound heterozygous; p.T234I; p.T71M |
Gollasch et al. [24] | 43 years, female | Polyuria, thirst | 3.0 | 25.7 | Normal | Blood creatinine 1.13 mg/dl, nephrocalcinosis, hypercalciuria; fractional excretion of sodium 2.3% and chloride 2.5%; high transtubular potassium gradient |
Compound heterozygous; p.I66N; p.R292Q |
Sharma et al. [25] | 9 years, female | Polyuria, polydipsia by 2-year | 2.5 | 32.5 | 5–10th centile | Nephrocalcinosis, hypercalciuria; mild hypercalcemia, high urine chloride; high 1,25(OH)2 vitamin D |
Compound heterozygous; p.G90W; p.I211S |
Huang et al. [26] | 35 years, male | None | 2.8 | 33 | Normal | Nephrocalcinosis, hypercalciuria | Homozygous; p.L220F |
Present patient | 12 years, female | Polyhydramnios, polydipsia, polyuria; onset at 6–7 years | 4.2–4.5 | 23–25 | Normal | Nephrocalcinosis, hypercalciuria; high urine chloride; high parathyroid hormone, elevated fractional excretion of magnesium | Compound heterozygous; p.C49T; p.S219R |